BIO-TECHNE Corp vs Wheaton Precious Metals Corp — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Wheaton Precious Metals Corp trades at $103.33 (market cap $46.54B). The key difference: Wheaton Precious Metals Corp is far larger — about 4.2× BIO-TECHNE Corp's market cap, and Wheaton Precious Metals Corp pays the higher dividend (0.75%). Which is the better fit depends on your goals.
| TECH | WPM | |
|---|---|---|
Market Cap | $11.16B | $46.54B |
Sector | Health | Basic Materials |
52-Week High | $72.12 | $165.72 |
52-Week Low | $43.31 | $91.00 |
Enterprise Value | $11.24B | $44.39B |
Dividend Yield | 0.45% | 0.75% |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →